Current member

Home > Member > Current member
Name 전지민 (박사과정_6학기) 
Tel 031-219-5144 
E-mail jjim@ajou.ac.kr 

Publication list

1. Jeon et al., 3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis. J Cell Mol Med. 2017 Aug 7

2. Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell. 2014 Feb 13;156(4):730-43.

3. NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis. 2015 Mar;74(3):595-602.

4. Misexpression of Dickkopf-1 in endothelial cells, but not in chondrocytes or hypertrophic chondrocytes, causes defects in endochondral ossification. J Bone Miner Res. 2012 Jun;27(6):1335-44.

5. Jeon et al. Cytokine-like 1 knock-out mice (Cytl1-/-) show normal cartilage and bone development but exhibit augmented osteoarthritic cartilage destruction. J Biol Chem. 2011


Patent

1. 3'-시알릴락토오스 또는 이의 유도체를 유효성분으로 함유하는 퇴행성관절염의 예방 또는 치료용 조성물. 대한민국특허 등록: 10-1773066

2. 6'-시알릴락토오스 또는 이의 유도체를 유효성분으로 함유하는 퇴행성관절염의 예방 또는 치료용 조성물. 대한민국특허 등록: 10-1773067


Presentation at international conference

1. Jeon et al., 3'-Sialyllactose pevents osteoarthritic development by suppression of catabolic factor expression. 2018 Osteoarthritis Research Society International. Liverpool, UK
목록